David Woosuk Chang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
David Woosuk Chang has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
Rebecca M. Garza
From the Section of Plastic and Reconstructive Surgery, Department of Surgery, The University of Chicago Medicine & Biological Sciences
11 shared publicationsMaureen Beederman
From the Section of Plastic Surgery, Department of Surgery, University of Chicago Medical Center
5 shared publications- Adrian Ooi
Department of Plastic, Reconstructive and Aesthetic Surgery, Singapore General Hospital, Singapore
4 shared publications Chad M. Teven
Chicago, Ill. From the Section of Plastic and Reconstructive Surgery, University of Chicago Medicine
4 shared publicationsAmir Inbal
Section of Plastic and Reconstructive Surgery, The University of Chicago Medicine, Chicago, Illinois
3 shared publicationsIsao Koshima
International Center for Lymphedema, Minami-ku, Hiroshima, Japan
3 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
Assessment and Management of Extremity Lymphedema: Position Paper of WSRM
This position paper was developed by the World Society for Reconstructive Microsurgery Task Force on Lymphedema to establish consensus-based recommendations for the management of extremity lymphedema. The document addresses key domains of care, including assessment, treatment strategies, surgical interventions, and postoperative management, with the goal of providing practical and adaptable guidance applicable across diverse clinical settings. Effective management of extremity lymphedema requires a structured and standardized approach encompassing comprehensive evaluation, individualized treatment, and long-term follow-up. Initial assessment should include a detailed history and physical examination, supplemented by standardized limb circumference measurements and clinical photography to ensure objective and reproducible documentation. Imaging modalities, such as lymphoscintigraphy and indocyanine green (ICG) fluorescent lymphography, are essential for accurate disease characterization and surgical planning. Preoperative optimization with conservative therapy and compression remains a critical step prior to intervention. Surgical management should be tailored to disease severity and patient-specific factors, incorporating physiologic procedures—including lymphaticovenous anastomosis (LVA), vascularized lymph node transfer (VLNT), and lymphaticovenular anastomosis (LNVA)—as well as excisional techniques such as liposuction and direct excision when indicated. Postoperative care should include regular noninvasive assessments at 3-month intervals and annual imaging to monitor outcomes. Long-term follow-up, extending up to 5 years, is recommended to ensure sustained clinical improvement and to guide ongoing management.
- 28 September 2026
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
Open AccessAssessment and Management of Extremity Lymphedema: Position Paper of WSRM
This position paper was developed by the World Society for Reconstructive Microsurgery Task Force on Lymphedema to establish consensus-based recommendations for the management of extremity lymphedema. The document addresses key domains of care, including assessment, treatment strategies, surgical interventions, and postoperative management, with the goal of providing practical and adaptable guidance applicable across diverse clinical settings. Effective management of extremity lymphedema requires a structured and standardized approach encompassing comprehensive evaluation, individualized treatment, and long-term follow-up. Initial assessment should include a detailed history and physical examination, supplemented by standardized limb circumference measurements and clinical photography to ensure objective and reproducible documentation. Imaging modalities, such as lymphoscintigraphy and indocyanine green (ICG) fluorescent lymphography, are essential for accurate disease characterization and surgical planning. Preoperative optimization with conservative therapy and compression remains a critical step prior to intervention. Surgical management should be tailored to disease severity and patient-specific factors, incorporating physiologic procedures—including lymphaticovenous anastomosis (LVA), vascularized lymph node transfer (VLNT), and lymphaticovenular anastomosis (LNVA)—as well as excisional techniques such as liposuction and direct excision when indicated. Postoperative care should include regular noninvasive assessments at 3-month intervals and annual imaging to monitor outcomes. Long-term follow-up, extending up to 5 years, is recommended to ensure sustained clinical improvement and to guide ongoing management.
- 16 October 2025
- Published by Elsevier in Clinics in Plastic Surgery
- Vol. 53 (1) , 23-31
Lymphedema
- Open Access
- 20 May 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (9) , 1-9
Educational Review: Management of Lymphedema—Approaches, Evidence for Surgical and Nonsurgical Interventions
Background: We aim to review the current medical and surgical management strategies for lymphedema and present methods for their successful integration into clinical practice. In addition, the following summary background data is provided. Lymphedema is a chronic condition resulting from impaired lymphatic drainage, leading to significant morbidity and reduced quality of life. Traditional management includes conservative therapies such as compression garments and physical therapy. However, advancements in surgical techniques have opened new avenues for treatment. This review aims to synthesize the available literature on both medical and surgical approaches to lymphedema management. Materials and Methods: This article explores the senior author’s strategies and experiences in lymphedema treatment, supplemented by a literature review that supports the described techniques. Results: Effective lymphedema management is multifaceted, necessitating accurate diagnosis, medical treatment, and in some cases, surgical intervention. The senior author has sought to streamline his approach to this complex condition, and this article outlines his algorithm and techniques for treatment. Conclusions: While conservative treatments remain the foundation of lymphedema management, surgical options in the properly selected patients have shown promising results. The integration of these approaches could enhance overall treatment efficacy and improve quality of life for individuals affected by lymphedema.
- 20 May 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (9) , 1-9
Open AccessEducational Review: Management of Lymphedema—Approaches, Evidence for Surgical and Nonsurgical Interventions
Background: We aim to review the current medical and surgical management strategies for lymphedema and present methods for their successful integration into clinical practice. In addition, the following summary background data is provided. Lymphedema is a chronic condition resulting from impaired lymphatic drainage, leading to significant morbidity and reduced quality of life. Traditional management includes conservative therapies such as compression garments and physical therapy. However, advancements in surgical techniques have opened new avenues for treatment. This review aims to synthesize the available literature on both medical and surgical approaches to lymphedema management. Materials and Methods: This article explores the senior author’s strategies and experiences in lymphedema treatment, supplemented by a literature review that supports the described techniques. Results: Effective lymphedema management is multifaceted, necessitating accurate diagnosis, medical treatment, and in some cases, surgical intervention. The senior author has sought to streamline his approach to this complex condition, and this article outlines his algorithm and techniques for treatment. Conclusions: While conservative treatments remain the foundation of lymphedema management, surgical options in the properly selected patients have shown promising results. The integration of these approaches could enhance overall treatment efficacy and improve quality of life for individuals affected by lymphedema.
- Open Access
- 29 December 2024
- Published by Wiley in Journal of Surgical Oncology
- Vol. 131 (7) , 1393-1399
A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction
Background and Objectives: Immediate lymphatic reconstruction (ILR) performed to prevent breast cancer related lymphedema is not consistently covered by insurance payors in the United States.Methods: Retrospective review was performed on a prospective database of ILR candidates from 2018 to 2022. Candidates were identified as patients with clinical axillary lymph node involvement at the time of breast cancer diagnosis. Patient demographics, insurance type, and development of lymphedema were recorded.Results: One hundred and eighty ILR candidates were identified, 50 of whom underwent ILR. Non‐ILR patients were more likely to be of black race, have Medicaid health insurance, earn lower median household income, and have lower rates of out‐of‐pocket payment when not covered by insurance. In 40 cases where ILR was indicated but not performed, 55% were due to financial reasons. After a minimum of 1 year follow up, 14.6% (6/41) of patients who underwent ILR had lymphedema, compared with 12.5% (9/72) of patients who had no clinical indication for ILR and 40% (10/25) of patients who did not undergo ILR when clinically indicated (p = 0.012).Conclusions: Disparities in insurance coverage and financial resources may adversely impact access and outcomes in patients clinically indicated for ILR.
- 29 December 2024
- Published by Wiley in Journal of Surgical Oncology
- Vol. 131 (7) , 1393-1399
Open AccessA Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction
Background and Objectives: Immediate lymphatic reconstruction (ILR) performed to prevent breast cancer related lymphedema is not consistently covered by insurance payors in the United States.Methods: Retrospective review was performed on a prospective database of ILR candidates from 2018 to 2022. Candidates were identified as patients with clinical axillary lymph node involvement at the time of breast cancer diagnosis. Patient demographics, insurance type, and development of lymphedema were recorded.Results: One hundred and eighty ILR candidates were identified, 50 of whom underwent ILR. Non‐ILR patients were more likely to be of black race, have Medicaid health insurance, earn lower median household income, and have lower rates of out‐of‐pocket payment when not covered by insurance. In 40 cases where ILR was indicated but not performed, 55% were due to financial reasons. After a minimum of 1 year follow up, 14.6% (6/41) of patients who underwent ILR had lymphedema, compared with 12.5% (9/72) of patients who had no clinical indication for ILR and 40% (10/25) of patients who did not undergo ILR when clinically indicated (p = 0.012).Conclusions: Disparities in insurance coverage and financial resources may adversely impact access and outcomes in patients clinically indicated for ILR.
- 12 November 2024
- Published by Springer Nature
- p. 25-33
Physiologic Surgery of Lymphedema (Overall Description of All Procedures, Including LVB, LNF, and VLNT)
- 12 November 2024
- Published by Springer Nature
- p. 25-33
Physiologic Surgery of Lymphedema (Overall Description of All Procedures, Including LVB, LNF, and VLNT)
- 10 October 2024
- Published by Wiley in Journal of Surgical Oncology
- Vol. 131 (1) , 5
Introduction of the 10th World Symposium for Lymphedema Surgery
- 10 October 2024
- Published by Wiley in Journal of Surgical Oncology
- Vol. 131 (1) , 5
Introduction of the 10th World Symposium for Lymphedema Surgery
- 1 March 2024
- Published by AME Publishing Company in Annals of Breast Surgery
- Vol. 8, 6
Lymphovenous bypass
Review Article Lymphovenous bypass Anne Huang, David W. Chang
- 1 March 2024
- Published by AME Publishing Company in Annals of Breast Surgery
- Vol. 8, 6
Lymphovenous bypass
Review Article Lymphovenous bypass Anne Huang, David W. Chang
- 29 November 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 152 (6) , 1131e-1142e
Optimizing Outcomes in Lymphedema Reconstruction
Learning Objectives: After studying this article, the participant should be able to: 1. Describe current surgical techniques for treating primary and secondary lymphedema. 2. Optimize the surgical care of patients with lymphedema. Summary: Over the past decade, significant advances have been made in the surgical treatment of lymphedema. The most notable changes have been the reintroduction and evolution of physiologic techniques, including lymphovenous bypass—sometimes referred to as lymphovenous anastomosis in the literature—and vascularized lymph node transplant. These surgical modalities are now often used as first-line surgical options or may be combined with nonphysiologic approaches, including direct excision and suction-assisted lipectomy. Surgeons continue to debate the most appropriate sequence and combination of surgical treatment, particularly for patients at both extremes of the severity spectrum. Furthermore, debate remains around the need to apply different treatment approaches for patients with upper versus lower extremity involvement and primary versus secondary cause. In this article, we provide a summary of the surgical techniques currently used for both primary and secondary lymphedema and provide our recommendations for optimizing the surgical care of patients with lymphedema.
- 29 November 2023
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 152 (6) , 1131e-1142e
Optimizing Outcomes in Lymphedema Reconstruction
Learning Objectives: After studying this article, the participant should be able to: 1. Describe current surgical techniques for treating primary and secondary lymphedema. 2. Optimize the surgical care of patients with lymphedema. Summary: Over the past decade, significant advances have been made in the surgical treatment of lymphedema. The most notable changes have been the reintroduction and evolution of physiologic techniques, including lymphovenous bypass—sometimes referred to as lymphovenous anastomosis in the literature—and vascularized lymph node transplant. These surgical modalities are now often used as first-line surgical options or may be combined with nonphysiologic approaches, including direct excision and suction-assisted lipectomy. Surgeons continue to debate the most appropriate sequence and combination of surgical treatment, particularly for patients at both extremes of the severity spectrum. Furthermore, debate remains around the need to apply different treatment approaches for patients with upper versus lower extremity involvement and primary versus secondary cause. In this article, we provide a summary of the surgical techniques currently used for both primary and secondary lymphedema and provide our recommendations for optimizing the surgical care of patients with lymphedema.
- 20 October 2022
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 151 (1) , 217-224
Health Disparities in Patients Seeking Physiological Surgical Treatment for Lymphedema
Background: Previous studies have demonstrated racial disparities in breast cancer treatment and secondary lymphedema. However, no studies have yet examined the effects of race and socioeconomic status on physiological surgical treatment for lymphedema. The authors aimed to evaluate whether disparities exist within patients seeking physiological surgical lymphedema treatment. Methods: A retrospective review was performed of patients presenting for physiological surgical treatment of lymphedema from 2013 to 2019. Data on demographics, medical history, socioeconomic factors, lymphedema, and treatments were collected. Results: A total of 789 patients (712 women and 77 men) seeking physiological surgical treatment of lymphedema were selected. Their mean age was 54.4 ± 13.4 years. A total of 620 patients (78.5%) self-reported as White, 120 (15.2%) as Black, 17 (2.2%) as Asian, five (0.6%) as Hispanic, and eight (2.4%) as multiracial. A total of 566 patients (71.7%) met criteria for surgical candidacy. White race was associated with increased rates of surgical candidacy compared with Black race (46.6% versus 77.2%; P < 0.0001). Compared with White patients, Black patients presented with a longer symptom duration (11.07 versus 6.99 years; P < 0.001), had a higher body mass index (mean, 34.5 versus 28.1; P < 1 × 10–10), had a higher International Society of Lymphology stage (P < 0.05), and were less likely to have maximized medical treatment for lymphedema (30.8% versus 55.4%; P < 0.01). Conclusions: This study demonstrates racial disparities in patients seeking physiological surgical treatment for lymphedema. Black patients present later with more severe disease, receive less nonsurgical treatment before consultation, and are less likely to meet criteria for physiological surgery. Improved patient and provider education on lymphedema and appropriate diagnosis and nonsurgical treatment is of primary importance to address this disparity.
- 20 October 2022
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 151 (1) , 217-224
Health Disparities in Patients Seeking Physiological Surgical Treatment for Lymphedema
Background: Previous studies have demonstrated racial disparities in breast cancer treatment and secondary lymphedema. However, no studies have yet examined the effects of race and socioeconomic status on physiological surgical treatment for lymphedema. The authors aimed to evaluate whether disparities exist within patients seeking physiological surgical lymphedema treatment. Methods: A retrospective review was performed of patients presenting for physiological surgical treatment of lymphedema from 2013 to 2019. Data on demographics, medical history, socioeconomic factors, lymphedema, and treatments were collected. Results: A total of 789 patients (712 women and 77 men) seeking physiological surgical treatment of lymphedema were selected. Their mean age was 54.4 ± 13.4 years. A total of 620 patients (78.5%) self-reported as White, 120 (15.2%) as Black, 17 (2.2%) as Asian, five (0.6%) as Hispanic, and eight (2.4%) as multiracial. A total of 566 patients (71.7%) met criteria for surgical candidacy. White race was associated with increased rates of surgical candidacy compared with Black race (46.6% versus 77.2%; P < 0.0001). Compared with White patients, Black patients presented with a longer symptom duration (11.07 versus 6.99 years; P < 0.001), had a higher body mass index (mean, 34.5 versus 28.1; P < 1 × 10–10), had a higher International Society of Lymphology stage (P < 0.05), and were less likely to have maximized medical treatment for lymphedema (30.8% versus 55.4%; P < 0.01). Conclusions: This study demonstrates racial disparities in patients seeking physiological surgical treatment for lymphedema. Black patients present later with more severe disease, receive less nonsurgical treatment before consultation, and are less likely to meet criteria for physiological surgery. Improved patient and provider education on lymphedema and appropriate diagnosis and nonsurgical treatment is of primary importance to address this disparity.
- Open Access
- 29 September 2022
- Published by Wiley in Microsurgery
- Vol. 42 (8) , 852-855
To spare or not to spare rib: A survey on internal mammary vessel preparation in microsurgical breast reconstruction
- 29 September 2022
- Published by Wiley in Microsurgery
- Vol. 42 (8) , 852-855
Open AccessTo spare or not to spare rib: A survey on internal mammary vessel preparation in microsurgical breast reconstruction